| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 03/22/2007 | US20070066584 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: 1'-{[1-(4-Chlorophenyl)cyclo-pentyl]carbonyl}-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents |
| 03/22/2007 | US20070066583 Monocyclic and bicyclic compounds and methods of use |
| 03/22/2007 | US20070066573 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors |
| 03/22/2007 | US20070066542 Novel imidazole derivatives, their preparation and their use as medicaments |
| 03/22/2007 | US20070066488 Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics |
| 03/22/2007 | US20070066440 Automatic transmission |
| 03/22/2007 | US20070062413 Novel anthrapyridone compound, water-based magenta ink composition and inkjet recording method |
| 03/22/2007 | CA2622597A1 Histamine h3 agonist for use as therapeutic agent for lipid/glucose metabolic disorder |
| 03/22/2007 | CA2622372A1 2-aminopyrimidine derivatives as modulators of the histamine h4 receptor activity |
| 03/22/2007 | CA2619309A1 Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 03/21/2007 | EP1764365A1 A process for the preparation of sartan derivates and intermediates useful in such process |
| 03/21/2007 | EP1764358A2 Cyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain |
| 03/21/2007 | EP1764134A2 Tetrahydroindolone and purine derivatives linked to arylpiperazines |
| 03/21/2007 | EP1763531A1 Hepatitis c inhibitor peptide analogs |
| 03/21/2007 | EP1763525A2 Stable micronized candesartan cilexetil and methods for preparing thereof |
| 03/21/2007 | EP1763524A1 Indole derivatives and use thereof as kinase inhibitors |
| 03/21/2007 | EP1763518A1 Substituted 2-alkyl quinazolinone derivatives as parp inhibitors |
| 03/21/2007 | EP1763514A2 Cycloalkyl substituted pyrimidinediamine compounds and their uses |
| 03/21/2007 | EP1763303A1 Substituted pyridazine carboxamides and derivatives thereof |
| 03/21/2007 | EP1685126B1 Preparation of candesartan cilexetil |
| 03/21/2007 | EP1451177B1 Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine |
| 03/21/2007 | EP1401826B1 Pyrazole derivatives as hiv reverse transcriptase inhibitors |
| 03/21/2007 | EP1231982B1 Use of phthalazine derivatives for the treatment of neurodegenerative diseases |
| 03/21/2007 | CN1934213A Material for organic electroluminescence device and organic electroluminescence device utilizing the same |
| 03/21/2007 | CN1934113A Compositions useful as inhibitors of protein kinases |
| 03/21/2007 | CN1934102A New process for the preparation of diazine derivatives |
| 03/21/2007 | CN1934101A Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 03/21/2007 | CN1934100A Substituted quinazoline or pyridopyrimidine derivative |
| 03/21/2007 | CN1934094A Diaryl-substituted five-membered heterocycle derivative |
| 03/21/2007 | CN1934091A Imidazole compounds for the treatment of neurodegenerative disorders |
| 03/21/2007 | CN1934090A Substituted n-cyclohexyl imidazolinones having an mch-modulatory effect |
| 03/21/2007 | CN1934088A 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 03/21/2007 | CN1934083A 2,7-substituted 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octan amide derivatives as renin inhibitors for the treatment of hypertension |
| 03/21/2007 | CN1934081A Novel benayl(idene)-lactam derivatives |
| 03/21/2007 | CN1933839A Compounds and methods of use |
| 03/21/2007 | CN1933838A Bipyridyl amides as modulators of metabotropic glutamate receptor-5 |
| 03/21/2007 | CN1933832A Ion channel modulators |
| 03/21/2007 | CN1933830A Indole derivatives and use thereof as kinase inhibitors in particular ik. k.2 inhibitors |
| 03/21/2007 | CN1931857A Prepn process of 5-losartan carboxylate |
| 03/21/2007 | CN1931827A 2- and 2,5-substituted phenylketo-enols |
| 03/21/2007 | CN1305871C Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2a receptor-related disorders |
| 03/21/2007 | CN1305850C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 03/21/2007 | CN1305847C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 03/20/2007 | US7193089 Process for manufacture of telmisartan |
| 03/20/2007 | US7193084 Crystal structure determined by differential scanning calorimetry and infrared analysis |
| 03/20/2007 | US7193083 Preparation of triazoles by organometallic addition to ketones and intermediates therefor |
| 03/20/2007 | US7193080 Color photography |
| 03/20/2007 | US7193065 activated haptens useful for generating immunogens to HIV protease inhibitors |
| 03/20/2007 | US7192983 N-protected/N-substituted-beta-amino hydroxy sulfonates |
| 03/20/2007 | US7192979 EP4 receptor selective agonist in the treatment of osteoporosis |
| 03/20/2007 | US7192977 Duocamycin prodrugs; binding to Dna |
| 03/20/2007 | US7192976 3-substituted pyrazoles; cell proliferation and angiogenesis promoters; antiapoptotosis and antifibrosis activity |
| 03/20/2007 | US7192973 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5) |
| 03/20/2007 | US7192957 3-Azabicyclo[3.1.0]hexane derivatives; human T-cell leukemia/lymphoma and lymphadenopathy associated virus; AIDS |
| 03/20/2007 | US7192954 Calcitonin Gene-Related Peptide (CGRP) antagonists for migraine and cluster headaches; 5'-acylamino-spiro[imidazolidine-4,2'-indane]-2,5-dione derivatives |
| 03/20/2007 | US7192950 Psychological disorders; eating disorders; dietetics |
| 03/20/2007 | US7192949 Anticarcinogenic and antiproliferative agents |
| 03/20/2007 | CA2297326C Heterocyclic compound and antitumor agent containing the same as active component |
| 03/15/2007 | WO2007030080A1 Heterocyclic compounds |
| 03/15/2007 | WO2007029629A1 Indolecarboxylic acid derivative having pgd2 receptor antagonistic activity |
| 03/15/2007 | WO2007029587A1 β SECRETASE INHIBITOR |
| 03/15/2007 | WO2007029156A2 Isoindoledione derivatives as adrenergic receptor antagonists |
| 03/15/2007 | WO2007029076A1 Isoindole derivatives as antimicrobial agents |
| 03/15/2007 | WO2007029036A2 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 03/15/2007 | WO2007029021A1 1,5-substituted tetrazoles as therapeutic compounds |
| 03/15/2007 | WO2007028445A1 6-indolyl-4-yl-amino-5-halogeno-2-pyrimidinyl-amino derivatives |
| 03/15/2007 | WO2006128692A3 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system |
| 03/15/2007 | WO2006060127A3 COMPOUNDS WITH MIXED PDE-INHIBITORY AND β-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITY FOR TREATMENT OF HEART FAILURE |
| 03/15/2007 | WO2006024823A9 Pyrimidine sulphonamide derivatives as chemokine receptor modulators |
| 03/15/2007 | US20070060753 Process for preparing intermediates useful to prepare certain antibacterial n-formyl hydroxylamines |
| 03/15/2007 | US20070060752 1-Phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases |
| 03/15/2007 | US20070060748 Compounds with mixed pde-inhibitory and beta-adrenergic antagonist or partial agonist activity for treatment of heart failure |
| 03/15/2007 | US20070060629 Large conductance calcium-activated k channel opener |
| 03/15/2007 | US20070060623 Acid secretion inhibitor |
| 03/15/2007 | US20070060621 Methods and compositions for the administration of prodrugs of proton pump inhibitors |
| 03/15/2007 | US20070060616 Methods for treating, preventing and managing chronic lymphocytic leukemia with indazole compounds |
| 03/15/2007 | US20070060601 Mitotic kinesin inhibitors |
| 03/15/2007 | US20070060594 Pyridinyl acetonitriles |
| 03/15/2007 | US20070060593 4-Carboxamido quinoline derivatives for use as nk-2 and nk-3 |
| 03/15/2007 | US20070060592 Chemokine receptor antagonists and methods of use therefor |
| 03/15/2007 | US20070060591 Amine substituted (dihydro- or tetrahydro-)quinoline, pyranopyridine, thiapyranopyridine, or naphthyridine derivatives as chemokine receptor modulators; lymphadenopathy associated, human T-cell leukemia/lymphoma, and/or feline immunodeficiency virus infections |
| 03/15/2007 | US20070060589 Inhibitors of protein arginine methyl transferases |
| 03/15/2007 | US20070060584 Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers |
| 03/15/2007 | US20070060582 1,4-Disubstituted isoquinilone derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases |
| 03/15/2007 | US20070060581 1-Sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands |
| 03/15/2007 | US20070060573 Acyltryptophanols |
| 03/15/2007 | US20070060572 e.g., 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine; mitogen-activated protein kinase inhibitor; antiinflammatory agent, autoimmune diseases |
| 03/15/2007 | US20070060571 e.g. 4-(5-(4-Chlorophenyl)-3-((nitrooxy)methyl)-3-hydropyrazolyl)benzenesulfonamide and nitric oxide donor (S-nitrosothiols, nitrites, nitrates, N-oxo-N-nitrosamines, sabstrate of nitric oxide synthase); analgesics, antiinflammatory agent, wound healing; gastrointestinal disorders; side effect reduction |
| 03/15/2007 | US20070060570 Sulfopyrroles |
| 03/15/2007 | US20070060569 Azacycloalkyl substituted acetic acid derivatives for use as MMP inhibitors |
| 03/15/2007 | US20070060568 5HT2c receptor modulators |
| 03/15/2007 | US20070060566 Benzazepine derivatives as histamine h3 antagonists |
| 03/15/2007 | US20070060556 Barium salt of benzimidazole derivative |
| 03/15/2007 | US20070060523 Preparation of poly(4-aminopyrrole-2-carboxamide) having the terminal amide group substituted with a 2-amidinoethyl- group; amidating the carbonyl chloride with 2-aminopropionitrile and subjecting the product to the Pinner reaction |
| 03/15/2007 | US20070057250 Light-emitting device, organic compound and display |
| 03/15/2007 | US20070056120 Cationic diaminopyrazoles, a process for producing them and colorants containing these compounds |
| 03/15/2007 | CA2621445A1 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 03/14/2007 | EP1762567A1 Pyrazole derivatives for treating HIV |
| 03/14/2007 | EP1761539A1 Indole derivative and use for treatment of cancer |
| 03/14/2007 | EP1761523A2 Triazinyl flvonate brighteners |